BH Oncology
We are shaping the future of immunotherapy
We are dedicated to advancing cancer immunotherapy research. Our mission is to drive innovation and enhance scientific understanding of immune-based approaches. We conduct investigational research into how the body's natural defenses may be studied in the context of cancer. Our work is investigational and is not offered as a treatment. Our focus on research and collaborative knowledge-sharing helps advance scientific understanding.
Areas of BHTS Immunotherapy Research
Using autologous dendritic killer T cells and dendritic cells programmed with a patient’s tumor biopsy specimen is an area of investigational research. These cellular products are investigational and are not offered as a treatment for any disease.
Personalized Therapy
Enhanced Immune Response
Reduced Off-Target Effects
Amplification
Overcoming Tumor Evasion
Systemic Toxicity Studies
Combinatorial Benefits
Versatile Application
Compatibility Research
Internships
Provide hands-on experience in the field of cancer immunotherapy research, helping students and early professionals gain valuable skills and insights.
Careers
Join us to advance cancer immunotherapy research. Apply now and help shape the future of immunotherapy science.
Investitors
Support BHTS Immunotherapy and be part of our effort to advance cancer immunotherapy research and innovation.

